Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01482715
Title A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | CAN

Facility Status City State Zip Country Details
UCSF San Francisco California 94155 United States Details
Sarah Cannon Research Institute Sarasota Florida 34232 United States Details
Dana-Farber Cancer Institute (Part 3 only) Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Princess Margaret Cancer Centre Toronto Ontario MSG 2M9 Canada Details
Sheba Medical Center Ramat Gan 52621 Israel Details
Tel Aviv Sourasky Medical Center Tel Aviv 632394 Israel Details
Hospital Vall d'Hebron Barcelona 8035 Spain Details
Guy's and St Thomas NHS Foundation Trust London England SE1 9RT United Kingdom Details
Royal Marsden NHS Foundation Trust London England SW3 6JJ United Kingdom Details
Imperial College Healthcare London England W12 0HS United Kingdom Details
Newcastle University Newcastle Upon Tyne England UK NE7 United Kingdom Details
Institution of Cancer Science, University of Glasgow Wolfson Wohl Cancer Research Glasgow Scotland G61 1QH United Kingdom Details
University College London Cancer Institute London WC1E 6BT United Kingdom Details
*Shaded cells indicate that there was no data available from for the field